Physician profile
Daniel J Lee
NPI 1336599679
$1,413.60
in general payments reported to CMS, 2019-2025
12 companies · $311 in 2025
The $311 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.90 · 2020: $383 · 2021: $185 · 2022: $129 · 2023: $108 · 2024: $285 · 2025: $311.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $704.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $703.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $477.76 | 2020-2023 | Scopis Ent |
| Inspire Medical Systems, INC. | $329.04 | 2023-2025 | Inspire |
| Aerin Medical INC. | $177.51 | 2024-2025 | |
| Zimmer Biomet Holdings, INC. | $123.61 | 2021 | |
| Laborie Medical Technologies Corp. | $89.10 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Boston Scientific Corporation | $61.75 | 2021 | |
| Intersect Ent, INC. | $42.50 | 2022 | |
| Genzyme Corporation | $40.48 | 2022-2024 | |
| Itamar Medical INC | $28.03 | 2022 | |
| Resmed Corp | $19.02 | 2023 | |
| Glaxosmithkline, LLC. | $12.90 | 2023 | Nucala |
| Optinose US, INC. | $11.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.